Wu Tsai Neurosciences Institute


Showing 271-280 of 566 Results

  • Clete A. Kushida, MD, PhD

    Clete A. Kushida, MD, PhD

    Professor of Psychiatry and Behavioral Sciences (Sleep Medicine)

    Current Research and Scholarly InterestsDr. Kushida is a neurologist and sleep specialist who directs several NIH- and industry-sponsored research studies, focused on topics such as the physical features and neurocognitive changes associated with the obstructive sleep apnea syndrome, the epidemiology and treatment of restless legs syndrome/periodic limb movement disorder, primary care sleep education and training, and countermeasures for sleep loss.

  • Tze Leung Lai

    Tze Leung Lai

    Member, Wu Tsai Neurosciences Institute

    Current Research and Scholarly InterestsResearch interests include clinical trial design, cancer biostatistics, survival analysis, adaptation and sequential experimentation, change-point detection and segmentation, stochastic optimization, time series and inference on stochastic processes, hidden Markov models and genomic applications.

  • Scott R. Lambert, MD

    Scott R. Lambert, MD

    Professor of Ophthalmology and, by courtesy, of Pediatrics

    Current Research and Scholarly InterestsMy research has focused on improving the visual outcomes of children with congenital cataracts. I organized a randomized clinical trial, the Infant Aphakia Treatment Study to compare the visual outcomes of infants optically corrected with a contact lens vs. an intraocular lens after unilateral cataract surgery. A second area of research has been ocular growth after cataract surgery.

  • James Landay

    James Landay

    Denning Co-Director (Acting) of Stanford HAI, Anand Rajaraman and Venky Harinarayan Professor and Senior Fellow at the Stanford Institute for HAI

    Current Research and Scholarly InterestsLanday's current research interests include Technology to Support Behavior Change (especially for health and sustainability), Demonstrational User Interfaces, Mobile & Ubiquitous Computing, Cross-Cultural Interface Design, Human-Centered AI, and User Interface Design Tools. He has developed tools, techniques, and a top professional book on Web Interface Design.

  • Joshua Landy

    Joshua Landy

    Andrew B. Hammond Professor of French Language, Literature and Civilization, and Professor of Comparative Literature and, by courtesy, of English and of Philosophy

    BioJoshua Landy is the Andrew B. Hammond Professor of French, Professor of Comparative Literature, and co-director of the Literature and Philosophy Initiative at Stanford, home to a PhD minor and undergraduate major tracks in Philosophy and Literature.

    Professor Landy is the author of Philosophy as Fiction: Self, Deception, and Knowledge in Proust (Oxford, 2004) and of How To Do Things with Fictions (Oxford, 2012). He is also the co-editor of two volumes, Thematics: New Approaches (SUNY, 1995, with Claude Bremond and Thomas Pavel) and The Re-Enchantment of the World: Secular Magic in a Rational Age (Stanford, 2009, with Michael Saler). Philosophy as Fiction deals with issues of self-knowledge, self-deception, and self-fashioning in Proust's A la recherche du temps perdu, while raising the question of what literary form contributes to an engagement with such questions; How to Do Things with Fictions explores a series of texts (by Plato, Beckett, Mallarmé, and Mark) that function as training-grounds for the mental capacities.

    Professor Landy has appeared on the NPR shows "Forum" and "Philosophy Talk" (on narrative selfhood and on the function of fiction) and has on various occasions been a guest host of Robert Harrison's "Entitled Opinions" (with Lera Boroditsky on Language and Thought, with Michael Saler on Re-Enchantment, with John Perry and Ken Taylor on the Uses of Philosophy, and with Alexander Nehamas on Beauty).

    Professor Landy has received the Walter J. Gores Award for Teaching Excellence (1999) and the Dean's Award for Distinguished Teaching (2001). As of Fall 2024, he is the Eleanor Loring Ritch University Fellow in Undergraduate Education.

  • Maarten Lansberg, MD, PhD

    Maarten Lansberg, MD, PhD

    Professor of Neurology and Neurological Sciences (Adult Neurology) and, by courtesy, of Neurosurgery
    On Partial Leave from 10/07/2024 To 01/05/2025

    Current Research and Scholarly InterestsMy research involves the design and conduct of clinical trials to discover new treatments for patients who have suffered a stroke. These trials span treatment of acute stroke, stroke recovery, and stroke prevention. My research in acute stroke is primarily focused on the use of advanced neuroimaging methods (CT and MRI) to select patients who are most likely to benefit from therapies aimed at restoring blood flow to the brain in patients who have suffered a stroke.

  • Tobias Lanz

    Tobias Lanz

    Assistant Professor of Medicine (Immunology and Rheumatology)

    BioTobias Lanz, MD is an Assistant Professor at the Institute for Immunity, Transplantation, and Infection and the Division of Immunology and Rheumatology at Stanford. His research focuses on B cell biology in neuroimmunological diseases and rheumatic diseases with neurological manifestations. He uses high-throughput screening technologies, and methods from structural and cell biology to identify new autoantigens and to understand how certain self-reactive B cells escape tolerance mechanisms. He is particularly interested in molecular mechanisms that explain the association between Epstein Barr Virus (EBV) and autoimmunity.
    Tobias went to medical school at the Eberhard Karls University in Tübingen, Germany and at the University College of London. He wrote his MD thesis at Dr. Michael Platten's laboratory at the Hertie Institute for Clinical Brain Research in Tübingen, Germany before joining Dr. Lawrence Steinman’s neuroimmunological laboratory at Stanford as a research scholar. After medical school he pursued his scientific and clinical training at the German Cancer Research Center (DKFZ) and the Department of Neurology at the University Hospital in Heidelberg, Germany. In 2015 he joined Dr. William Robinson’s lab at Stanford, where he investigated environmental triggers of autoimmunity, including viruses and milk consumption. In his most recent work, he characterized the B cell repertoire in the spinal fluid of patients with multiple sclerosis (MS) and identified molecular mimicry between EBV EBNA1 and the glial cellular adhesion molecule GlialCAM as a driver of neuroinflammation (Lanz et al., Nature, 2022). His long term objective is to leverage these newly discovered mechanistic insights to develop next-generation biomarkers and therapeutics for autoimmune diseases.

  • Carolyn Lee MD PhD

    Carolyn Lee MD PhD

    Assistant Professor of Dermatology

    BioA native of Queens, New York, Dr. Carolyn Lee joined the Stanford Dermatology faculty in February of 2016 as a specialist in the management of patients at a high risk for developing skin cancer. This year, she has been a featured presenter at both the Society for Investigative Dermatology Annual Meeting and the Gordon Research Conference on Epithelial Differentiation and Keratinization. Dr. Lee graduated with honors from Yale University in 1998 with a BS in Biology and received her MD and PhD from Georgetown University with a specialty in tumor biology in 2006. She completed her Dermatology residency at Stanford in 2010 and a Postdoctoral Fellowship in epithelial biology in the lab of Dr. Paul Khavari in December of 2015. Dr. Lee possesses a strong interest in understanding the mechanisms of high-risk non-melanoma skin cancer and is currently a member of Stanford’s High-Risk Non-Melanoma Skin Cancer Working Group.

  • Jennifer Lee

    Jennifer Lee

    Professor of Medicine (Endocrinology) and, by courtesy, of Epidemiology and Population Health

    Current Research and Scholarly InterestsI am a clinical scientist (PhD epidemiology), endocrinologist, and CMO at VAPA Cooperative Studies Program Coordinating Center. My group does pattern and prediction mapping along the life-course of interventions/outcomes and how healthcare system can positively impact health longitudinally. We use novel molecular epi, 'big' data like EHRs using multiple designs/methods/technologies. These interests cut across multiple complex chronic diseases and lifespan.
    https://med.stanford.edu/jleelab.html